Antiviral agents.
D000179:Acrylates / Q000494:pharmacology; D000547:Amantadine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000578:Amidines / Q000494:pharmacology; D000596:Amino Acids / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000998:Antiviral Agents; D001562:Benzimidazoles / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D046508:Culture Techniques; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology; D006566:Herpesviridae Infections / Q000188:drug therapy; D006571:Heterocyclic Compounds / Q000494:pharmacology; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007251:Influenza, Human / Q000188:drug therapy; D007372:Interferons / Q000096:biosynthesis; D007546:Isoquinolines / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology; D011119:Polynucleotides / Q000627:therapeutic use; D012313:RNA / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013882:Thiosemicarbazones / Q000494:pharmacology; D014227:Triazines / Q000494:pharmacology
D000179:Acrylates; D000578:Amidines; D000596:Amino Acids; D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D001562:Benzimidazoles; D006146:Guanidines; D006571:Heterocyclic Compounds; D007546:Isoquinolines; D010455:Peptides; D011119:Polynucleotides; D013882:Thiosemicarbazones; D014227:Triazines; D003561:Cytarabine; D012313:RNA; D007372:Interferons; D000547:Amantadine; D007065:Idoxuridine; D012293:Rifampin; D003630:Daunorubicin